 David Albers
Concepts (267)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electronic Health Records | 17 | 2023 | 1069 | 2.590 |
Why?
| | Blood Glucose | 11 | 2023 | 2186 | 1.740 |
Why?
| | Machine Learning | 10 | 2025 | 493 | 1.540 |
Why?
| | Data Mining | 9 | 2019 | 116 | 1.390 |
Why?
| | Algorithms | 10 | 2025 | 1704 | 1.310 |
Why?
| | Glucose | 6 | 2023 | 1020 | 1.290 |
Why?
| | Common Bile Duct Neoplasms | 3 | 2025 | 30 | 1.210 |
Why?
| | Ampulla of Vater | 3 | 2025 | 42 | 1.200 |
Why?
| | Models, Statistical | 8 | 2020 | 669 | 1.150 |
Why?
| | Models, Biological | 5 | 2019 | 1783 | 1.030 |
Why?
| | Cerebrovascular Circulation | 3 | 2025 | 243 | 0.990 |
Why?
| | Ventilator-Induced Lung Injury | 2 | 2024 | 59 | 0.970 |
Why?
| | Diabetes Mellitus, Type 2 | 8 | 2023 | 2531 | 0.930 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2025 | 145 | 0.910 |
Why?
| | Myotomy | 1 | 2024 | 13 | 0.890 |
Why?
| | Esophageal Motility Disorders | 1 | 2024 | 27 | 0.870 |
Why?
| | Manometry | 1 | 2024 | 95 | 0.870 |
Why?
| | Endocrine System | 2 | 2014 | 20 | 0.840 |
Why?
| | Critical Care | 4 | 2025 | 601 | 0.830 |
Why?
| | Intensive Care Units, Pediatric | 2 | 2025 | 233 | 0.810 |
Why?
| | Duodenal Neoplasms | 1 | 2023 | 23 | 0.790 |
Why?
| | Phenotype | 5 | 2023 | 3196 | 0.740 |
Why?
| | Homeostasis | 1 | 2025 | 621 | 0.740 |
Why?
| | Lung Injury | 1 | 2024 | 219 | 0.700 |
Why?
| | Patient-Specific Modeling | 2 | 2019 | 41 | 0.690 |
Why?
| | Pancreatic Neoplasms | 3 | 2023 | 938 | 0.670 |
Why?
| | Brain Injuries, Traumatic | 1 | 2025 | 360 | 0.670 |
Why?
| | Patient Generated Health Data | 2 | 2018 | 2 | 0.660 |
Why?
| | Polycystic Ovary Syndrome | 1 | 2023 | 177 | 0.650 |
Why?
| | Clinical Laboratory Techniques | 2 | 2018 | 97 | 0.630 |
Why?
| | Blood Pressure | 2 | 2025 | 1786 | 0.610 |
Why?
| | Ventilators, Mechanical | 4 | 2024 | 58 | 0.600 |
Why?
| | Insulin | 10 | 2023 | 2409 | 0.570 |
Why?
| | Subarachnoid Hemorrhage | 5 | 2017 | 66 | 0.560 |
Why?
| | Intensive Care Units | 7 | 2025 | 827 | 0.550 |
Why?
| | Diabetes Mellitus | 4 | 2023 | 1040 | 0.530 |
Why?
| | Humans | 65 | 2025 | 137585 | 0.530 |
Why?
| | High-Throughput Screening Assays | 1 | 2018 | 158 | 0.500 |
Why?
| | Respiration, Artificial | 4 | 2024 | 645 | 0.490 |
Why?
| | Diet Records | 1 | 2016 | 83 | 0.490 |
Why?
| | Meals | 1 | 2016 | 125 | 0.440 |
Why?
| | Clinical Deterioration | 2 | 2025 | 11 | 0.420 |
Why?
| | Intracranial Pressure | 2 | 2025 | 49 | 0.410 |
Why?
| | Self Care | 1 | 2016 | 380 | 0.400 |
Why?
| | Computational Biology | 1 | 2017 | 644 | 0.380 |
Why?
| | Sepsis | 4 | 2025 | 617 | 0.380 |
Why?
| | Diffusion of Innovation | 1 | 2012 | 99 | 0.370 |
Why?
| | Shock, Septic | 2 | 2024 | 219 | 0.360 |
Why?
| | Population Dynamics | 1 | 2012 | 151 | 0.350 |
Why?
| | Blood Glucose Self-Monitoring | 4 | 2022 | 641 | 0.350 |
Why?
| | Information Storage and Retrieval | 1 | 2012 | 118 | 0.350 |
Why?
| | Monitoring, Physiologic | 3 | 2025 | 275 | 0.350 |
Why?
| | Biomarkers | 4 | 2024 | 4149 | 0.330 |
Why?
| | Self-Management | 2 | 2023 | 176 | 0.310 |
Why?
| | Diabetes Complications | 2 | 2020 | 227 | 0.300 |
Why?
| | Tidal Volume | 4 | 2024 | 86 | 0.280 |
Why?
| | Neuromuscular Blockade | 2 | 2018 | 31 | 0.280 |
Why?
| | Data Interpretation, Statistical | 3 | 2014 | 363 | 0.270 |
Why?
| | Heart Rate | 2 | 2025 | 822 | 0.260 |
Why?
| | Precision Medicine | 2 | 2020 | 429 | 0.250 |
Why?
| | Pattern Recognition, Automated | 2 | 2018 | 73 | 0.250 |
Why?
| | Delivery of Health Care | 1 | 2013 | 951 | 0.250 |
Why?
| | Retrospective Studies | 11 | 2025 | 15657 | 0.240 |
Why?
| | Pancreaticoduodenectomy | 2 | 2025 | 164 | 0.230 |
Why?
| | Blood Culture | 1 | 2025 | 23 | 0.230 |
Why?
| | Esophageal Sphincter, Lower | 1 | 2024 | 14 | 0.220 |
Why?
| | Computer Simulation | 3 | 2014 | 978 | 0.220 |
Why?
| | Natural Orifice Endoscopic Surgery | 1 | 2024 | 34 | 0.220 |
Why?
| | Treatment Outcome | 6 | 2025 | 10811 | 0.220 |
Why?
| | Esophageal Achalasia | 1 | 2024 | 30 | 0.220 |
Why?
| | Epilepsy, Generalized | 2 | 2014 | 19 | 0.210 |
Why?
| | Diabetes Mellitus, Type 1 | 5 | 2020 | 3715 | 0.210 |
Why?
| | Endoscopy, Gastrointestinal | 2 | 2023 | 228 | 0.210 |
Why?
| | Female | 20 | 2025 | 73304 | 0.200 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2023 | 39 | 0.200 |
Why?
| | Esophagoscopy | 1 | 2024 | 209 | 0.200 |
Why?
| | Bacteremia | 1 | 2025 | 214 | 0.200 |
Why?
| | Adenoma | 1 | 2025 | 230 | 0.190 |
Why?
| | Bacterial Infections | 1 | 2024 | 250 | 0.190 |
Why?
| | Male | 20 | 2025 | 67762 | 0.190 |
Why?
| | Hormones | 1 | 2023 | 143 | 0.190 |
Why?
| | Stroke | 2 | 2024 | 1120 | 0.190 |
Why?
| | Lung | 3 | 2024 | 4060 | 0.190 |
Why?
| | Menstrual Cycle | 1 | 2023 | 133 | 0.190 |
Why?
| | Middle Aged | 15 | 2025 | 33479 | 0.180 |
Why?
| | Gastrointestinal Neoplasms | 1 | 2022 | 77 | 0.180 |
Why?
| | Cholangiocarcinoma | 1 | 2023 | 104 | 0.180 |
Why?
| | Regression Analysis | 3 | 2018 | 1024 | 0.180 |
Why?
| | Acute Lung Injury | 1 | 2024 | 287 | 0.180 |
Why?
| | Adult | 13 | 2025 | 37929 | 0.180 |
Why?
| | Bile Duct Neoplasms | 1 | 2023 | 124 | 0.180 |
Why?
| | Health Equity | 1 | 2023 | 99 | 0.180 |
Why?
| | Self Expandable Metallic Stents | 1 | 2021 | 16 | 0.180 |
Why?
| | Stomach Neoplasms | 1 | 2022 | 122 | 0.170 |
Why?
| | Esophageal and Gastric Varices | 1 | 2021 | 40 | 0.170 |
Why?
| | Neuroendocrine Tumors | 1 | 2022 | 116 | 0.170 |
Why?
| | Models, Theoretical | 3 | 2015 | 578 | 0.170 |
Why?
| | Intracranial Hypertension | 1 | 2021 | 40 | 0.170 |
Why?
| | Pancreas | 1 | 2023 | 329 | 0.170 |
Why?
| | Nutritionists | 1 | 2020 | 19 | 0.170 |
Why?
| | Hematoma | 1 | 2019 | 53 | 0.150 |
Why?
| | Decision Support Systems, Clinical | 1 | 2022 | 226 | 0.150 |
Why?
| | Insulin-Secreting Cells | 1 | 2023 | 377 | 0.150 |
Why?
| | Normal Distribution | 1 | 2018 | 21 | 0.150 |
Why?
| | Cerebral Hemorrhage | 1 | 2019 | 108 | 0.150 |
Why?
| | Computer Graphics | 1 | 2018 | 42 | 0.150 |
Why?
| | Hospital Mortality | 4 | 2025 | 911 | 0.140 |
Why?
| | Communicable Diseases | 1 | 2020 | 159 | 0.140 |
Why?
| | Drug Therapy | 1 | 2018 | 85 | 0.140 |
Why?
| | Deep Sedation | 1 | 2018 | 14 | 0.140 |
Why?
| | Reproducibility of Results | 2 | 2023 | 3284 | 0.140 |
Why?
| | Prospective Studies | 8 | 2024 | 7604 | 0.140 |
Why?
| | Anemia | 1 | 2019 | 170 | 0.140 |
Why?
| | Time | 2 | 2015 | 83 | 0.140 |
Why?
| | Islets of Langerhans | 1 | 2023 | 803 | 0.140 |
Why?
| | Nutritional Status | 1 | 2020 | 350 | 0.140 |
Why?
| | Aged | 10 | 2025 | 23961 | 0.130 |
Why?
| | Hemoglobins | 1 | 2019 | 353 | 0.130 |
Why?
| | Vital Signs | 3 | 2021 | 43 | 0.130 |
Why?
| | Data Collection | 3 | 2018 | 673 | 0.130 |
Why?
| | Bayes Theorem | 1 | 2018 | 405 | 0.130 |
Why?
| | Pharmaceutical Preparations | 1 | 2018 | 179 | 0.130 |
Why?
| | Health Educators | 1 | 2016 | 5 | 0.130 |
Why?
| | Cohort Studies | 5 | 2024 | 5742 | 0.130 |
Why?
| | Child | 8 | 2025 | 21935 | 0.120 |
Why?
| | Diet | 2 | 2020 | 1278 | 0.120 |
Why?
| | Hypertension | 2 | 2022 | 1295 | 0.120 |
Why?
| | Patient Care Team | 1 | 2020 | 631 | 0.110 |
Why?
| | Follow-Up Studies | 1 | 2024 | 5131 | 0.110 |
Why?
| | Clinical Laboratory Information Systems | 1 | 2014 | 7 | 0.110 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2017 | 250 | 0.110 |
Why?
| | Unnecessary Procedures | 1 | 2014 | 50 | 0.110 |
Why?
| | Organ Dysfunction Scores | 2 | 2024 | 48 | 0.110 |
Why?
| | Blood Chemical Analysis | 1 | 2014 | 99 | 0.110 |
Why?
| | Artifacts | 1 | 2014 | 129 | 0.100 |
Why?
| | Mathematical Concepts | 1 | 2013 | 31 | 0.100 |
Why?
| | Dental Records | 1 | 2013 | 2 | 0.100 |
Why?
| | Multiple Organ Failure | 2 | 2024 | 128 | 0.100 |
Why?
| | Epidemiology | 1 | 2013 | 33 | 0.100 |
Why?
| | Pandemics | 1 | 2021 | 1639 | 0.100 |
Why?
| | Periodontitis | 1 | 2013 | 53 | 0.100 |
Why?
| | Research Design | 2 | 2024 | 1139 | 0.100 |
Why?
| | Propensity Score | 2 | 2025 | 294 | 0.100 |
Why?
| | Quality Control | 1 | 2012 | 172 | 0.090 |
Why?
| | Databases, Factual | 2 | 2018 | 1357 | 0.090 |
Why?
| | Cross Infection | 1 | 2014 | 256 | 0.090 |
Why?
| | Telemedicine | 1 | 2020 | 862 | 0.090 |
Why?
| | Software | 2 | 2014 | 665 | 0.090 |
Why?
| | Brain Injuries | 1 | 2016 | 494 | 0.090 |
Why?
| | Guideline Adherence | 1 | 2014 | 556 | 0.080 |
Why?
| | Hospitalization | 2 | 2024 | 2199 | 0.080 |
Why?
| | Research | 1 | 2012 | 451 | 0.080 |
Why?
| | United States | 3 | 2024 | 14841 | 0.070 |
Why?
| | Brain | 2 | 2019 | 2668 | 0.070 |
Why?
| | Prognosis | 3 | 2022 | 4030 | 0.070 |
Why?
| | New York City | 2 | 2018 | 85 | 0.060 |
Why?
| | Pilot Projects | 2 | 2023 | 1710 | 0.060 |
Why?
| | Biomedical Research | 1 | 2012 | 692 | 0.060 |
Why?
| | Multivariate Analysis | 2 | 2019 | 1509 | 0.060 |
Why?
| | Positive-Pressure Respiration | 1 | 2024 | 80 | 0.060 |
Why?
| | Pressure | 1 | 2024 | 225 | 0.050 |
Why?
| | Incidence | 2 | 2020 | 2804 | 0.050 |
Why?
| | Academic Medical Centers | 2 | 2018 | 512 | 0.050 |
Why?
| | New York | 2 | 2014 | 126 | 0.050 |
Why?
| | Gap Junctions | 1 | 2023 | 59 | 0.050 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2024 | 93 | 0.050 |
Why?
| | Medical Records | 1 | 2024 | 177 | 0.050 |
Why?
| | Nonlinear Dynamics | 1 | 2023 | 88 | 0.050 |
Why?
| | Electroencephalography | 2 | 2017 | 423 | 0.050 |
Why?
| | Bile Ducts, Intrahepatic | 1 | 2023 | 78 | 0.050 |
Why?
| | Streptococcal Infections | 1 | 2024 | 151 | 0.050 |
Why?
| | Platinum | 1 | 2022 | 50 | 0.050 |
Why?
| | Albumins | 1 | 2023 | 114 | 0.050 |
Why?
| | Etoposide | 1 | 2022 | 158 | 0.050 |
Why?
| | Sinusitis | 1 | 2024 | 221 | 0.050 |
Why?
| | Deoxycytidine | 1 | 2023 | 179 | 0.050 |
Why?
| | Paclitaxel | 1 | 2023 | 230 | 0.050 |
Why?
| | Infant | 3 | 2025 | 9465 | 0.050 |
Why?
| | Blood Pressure Determination | 1 | 2022 | 157 | 0.050 |
Why?
| | Heart Arrest | 1 | 2025 | 339 | 0.040 |
Why?
| | Lipopolysaccharides | 1 | 2024 | 886 | 0.040 |
Why?
| | Cisplatin | 1 | 2023 | 320 | 0.040 |
Why?
| | Child, Preschool | 3 | 2025 | 11074 | 0.040 |
Why?
| | Consensus | 1 | 2024 | 683 | 0.040 |
Why?
| | Expert Systems | 1 | 2020 | 3 | 0.040 |
Why?
| | Uncertainty | 1 | 2021 | 128 | 0.040 |
Why?
| | Feedback | 1 | 2021 | 173 | 0.040 |
Why?
| | Respiratory Tract Infections | 1 | 2024 | 390 | 0.040 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2021 | 132 | 0.040 |
Why?
| | Patient Selection | 1 | 2024 | 696 | 0.040 |
Why?
| | Patient Readmission | 1 | 2025 | 697 | 0.040 |
Why?
| | Documentation | 1 | 2021 | 194 | 0.040 |
Why?
| | Length of Stay | 1 | 2025 | 1215 | 0.040 |
Why?
| | Wearable Electronic Devices | 1 | 2019 | 53 | 0.040 |
Why?
| | Motivation | 1 | 2023 | 570 | 0.040 |
Why?
| | Datasets as Topic | 1 | 2018 | 121 | 0.040 |
Why?
| | Pulmonary Surfactant-Associated Protein D | 1 | 2018 | 35 | 0.040 |
Why?
| | Area Under Curve | 1 | 2018 | 314 | 0.030 |
Why?
| | von Willebrand Factor | 1 | 2018 | 80 | 0.030 |
Why?
| | User-Computer Interface | 1 | 2018 | 159 | 0.030 |
Why?
| | Equipment Failure | 1 | 2018 | 108 | 0.030 |
Why?
| | Neurovascular Coupling | 1 | 2017 | 9 | 0.030 |
Why?
| | Ultrasonography, Doppler, Transcranial | 1 | 2017 | 45 | 0.030 |
Why?
| | Interleukin-8 | 1 | 2018 | 268 | 0.030 |
Why?
| | Stents | 1 | 2021 | 527 | 0.030 |
Why?
| | ROC Curve | 1 | 2018 | 554 | 0.030 |
Why?
| | Mobile Applications | 1 | 2019 | 183 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2023 | 1079 | 0.030 |
Why?
| | Nervous System Physiological Phenomena | 1 | 2016 | 21 | 0.030 |
Why?
| | Adolescent | 3 | 2025 | 21513 | 0.030 |
Why?
| | Multimodal Imaging | 1 | 2017 | 113 | 0.030 |
Why?
| | Signal-To-Noise Ratio | 1 | 2016 | 67 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2019 | 7635 | 0.030 |
Why?
| | Linear Models | 1 | 2018 | 849 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2018 | 1316 | 0.030 |
Why?
| | Organizational Case Studies | 1 | 2014 | 78 | 0.030 |
Why?
| | APACHE | 1 | 2014 | 69 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2024 | 4295 | 0.030 |
Why?
| | Medical Audit | 1 | 2014 | 78 | 0.030 |
Why?
| | Patient Care Management | 1 | 2014 | 57 | 0.030 |
Why?
| | Logistic Models | 1 | 2019 | 2074 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2024 | 5757 | 0.030 |
Why?
| | Cerebral Cortex | 1 | 2017 | 433 | 0.030 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 1692 | 0.030 |
Why?
| | Feeding Behavior | 1 | 2019 | 654 | 0.030 |
Why?
| | Brain Ischemia | 1 | 2017 | 338 | 0.030 |
Why?
| | Pubic Symphysis | 1 | 1973 | 3 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2014 | 431 | 0.030 |
Why?
| | Clinical Coding | 1 | 2013 | 26 | 0.030 |
Why?
| | Prostatic Hyperplasia | 1 | 2013 | 44 | 0.020 |
Why?
| | Ligaments, Articular | 1 | 1973 | 51 | 0.020 |
Why?
| | Parturition | 1 | 2013 | 71 | 0.020 |
Why?
| | Hyperlipidemias | 1 | 2013 | 120 | 0.020 |
Why?
| | Hypercholesterolemia | 1 | 2013 | 106 | 0.020 |
Why?
| | Databases as Topic | 1 | 2011 | 67 | 0.020 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2020 | 1329 | 0.020 |
Why?
| | Disease Progression | 1 | 2019 | 2757 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2014 | 513 | 0.020 |
Why?
| | Stress, Psychological | 1 | 2019 | 1100 | 0.020 |
Why?
| | Electrocardiography | 1 | 2014 | 629 | 0.020 |
Why?
| | Urinary Bladder | 1 | 1973 | 183 | 0.020 |
Why?
| | Tobacco Use Disorder | 1 | 2013 | 251 | 0.020 |
Why?
| | Hypoglycemic Agents | 1 | 2019 | 1291 | 0.020 |
Why?
| | Critical Illness | 1 | 2016 | 811 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2014 | 1946 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2019 | 2691 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2014 | 2031 | 0.020 |
Why?
| | Young Adult | 1 | 2024 | 13209 | 0.020 |
Why?
| | Exercise | 1 | 2019 | 2057 | 0.020 |
Why?
| | Time Factors | 1 | 2018 | 6828 | 0.020 |
Why?
| | Risk Assessment | 1 | 2017 | 3457 | 0.020 |
Why?
| | Mice | 1 | 2024 | 17787 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2014 | 2844 | 0.020 |
Why?
| | Alcoholism | 1 | 2013 | 807 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2014 | 1587 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2013 | 3556 | 0.010 |
Why?
| | Inflammation | 1 | 2014 | 2837 | 0.010 |
Why?
| | Animals | 1 | 2024 | 36940 | 0.010 |
Why?
| | Pregnancy | 1 | 2013 | 6763 | 0.010 |
Why?
| | Risk Factors | 1 | 2014 | 10388 | 0.010 |
Why?
| | Obesity | 1 | 2013 | 2992 | 0.010 |
Why?
| | Pubic Bone | 1 | 1973 | 6 | 0.010 |
Why?
| | Methods | 1 | 1973 | 65 | 0.010 |
Why?
| | Urethra | 1 | 1973 | 55 | 0.010 |
Why?
| | Urinary Incontinence | 1 | 1973 | 66 | 0.010 |
Why?
| | Prostate | 1 | 1973 | 175 | 0.010 |
Why?
| | Infant, Newborn | 1 | 1973 | 6079 | 0.000 |
Why?
|
|
Albers's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|